0000805928-22-000147.txt : 20221229
0000805928-22-000147.hdr.sgml : 20221229
20221229210114
ACCESSION NUMBER: 0000805928-22-000147
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221227
FILED AS OF DATE: 20221229
DATE AS OF CHANGE: 20221229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Donovan Michael Patrick
CENTRAL INDEX KEY: 0001653918
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36046
FILM NUMBER: 221500098
MAIL ADDRESS:
STREET 1: C/O AXOGEN, INC.
STREET 2: 13631 PROGRESS BLVD. SUITE 400
CITY: ALACHUA
STATE: FL
ZIP: 32615
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axogen, Inc.
CENTRAL INDEX KEY: 0000805928
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 411301878
STATE OF INCORPORATION: MN
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13631 PROGRESS BLVD.
STREET 2: SUITE 400
CITY: ALACHUA
STATE: FL
ZIP: 32615
BUSINESS PHONE: (386) 462-6817
MAIL ADDRESS:
STREET 1: 13631 PROGRESS BLVD.
STREET 2: SUITE 400
CITY: ALACHUA
STATE: FL
ZIP: 32615
FORMER COMPANY:
FORMER CONFORMED NAME: AxoGen, Inc.
DATE OF NAME CHANGE: 20111004
FORMER COMPANY:
FORMER CONFORMED NAME: LECTEC CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
wf-form4_167236565329566.xml
FORM 4
X0306
4
2022-12-27
0
0000805928
Axogen, Inc.
AXGN
0001653918
Donovan Michael Patrick
13631 PROGRESS BOULEVARD
SUITE 400
ALACHUA
FL
32615
0
1
0
0
VP Operations
Common Stock
2022-12-27
4
M
0
1150
0
A
65005
D
Common Stock
2022-12-27
4
F
0
286
9.44
D
64719
D
Restricted Stock Units
2022-12-27
4
M
0
1150
0
A
Common Stock
1150.0
0
D
This reflects the number of restricted stock units that vested on December 27, 2022.
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
All shares of AxoGen Inc. common stock underlying the restricted stock units vested on December 27, 2022 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter.
/s/Mike Donovan
2022-12-29